Elevated IgG Anticardiolipin Rate Linked with Increased Risk of Thrombotic Events in SLE Patients

Patients with systemic lupus erythematous had higher rates of thromboses when they had elevated rates of immunoglobulin G anticardiolipin and lupus anticoagulant, according to this study. Vinicius Domingues, MD, from the Department of Rheumatology at New York University School of Medicine in New York, and colleagues analyzed 1,390 patients in the Hopkins Lupus Cohort with… Read More »

Trigger May Be Uncovered For Lupus, Other Autoimmune Diseases

Scientists at the Hospital for Special Surgery (HSS) in New York, in collaboration with Greek researchers, may have identified a trigger for autoimmune disorders that could shed light on how many diseases develop, including lupus. The investigators found virus-like components of the human genome that seem to be associated with both lupus and Sjogren’s syndrome. The… Read More »

US Appropriations Committee Bill Includes $6 Million for Lupus Education and Research

A bill recently moved forward by the U.S. Senate Appropriations Committee on labor, health human services and education for 2017 includes $6 million for lupus research and education, in addition to $34 billion for medical research overall at the National Institutes of Health (NIH). Specifically, the committee bill supports funding for the Office of Minority Health’s National Health Education… Read More »

Elusive Target: A Rundown of the Drug Pipeline for Systemic Lupus Erythematosus

Systemic lupus erythematosus is a heterogeneous disease that requires a customized approach to its management. Therapies range from nonsteroidal anti-inflammatory drugs to one of any number of immunomodulators or biologics. However, the clinical community has yet to arrive at a perfect therapy or even a perfect combination of therapies. “Every patient with lupus is different,”… Read More »

The Lupus Alliance of LIQ; Encompassing a More Positive Attitude, Outlook and Outcome for all of Those Whose Lives are Touched by Lupus.

The Lupus Alliance of Long Island/Queens has been helping those with lupus in the Long Island/Queens community since 1955. With a steadfast mission of improving the lives of those living with lupus through awareness, education, support services and research. The Alliance has continued to be the only local resource for families whose lives are affected… Read More »

Benlysta Seems to Cut Flares in Lupus

LONDON — Adding belimumab (Benlysta) to standard treatments for systemic lupus erythematosus was associated with significantly lower rates of disease flares, a claims-based analysis revealed. In an “as treated” analysis, there was an approximately 30% decrease in the incidence rate of moderate-to-severe flares during the 12 months after the initiation of belimumab therapy, according to… Read More »